Figure 4.

The overall survival when examining therapeutic modality in the context of specific T3 disease characteristics. Lines were truncated when the number of patients at risk fell fewer than 10 for the cohort. A, tumor size (surgery followed by chemotherapy with or without radiation [S + CR], 32.4%; surgery alone [S], 13.9%). B, chest wall invasion (S + CR, 24.3%; S, 35.6%). C, additional nodule (S + CR, 34.5%; S, 23.5%). D, multiple T3 characteristics (S + CR, 28.9%; S, 32.4%). Shading above and below the lines drawn indicate 95% CI.